Issue 2/2002
Content (10 Articles)
Radiofrequency ablation of primary and metastatic hepatic malignancies
S. A. Curley, F. Izzo
Isolated hepatic perfusion chemotherapy for unresectable malignant hepatic tumors
Y. Ku, M. Tominaga, T. Iwasaki, T. Fukumoto, Y. Kuroda
NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese
N. Hamajima, K. Matsuo, H. Iwata, M. Shinoda, Y. Yamamura, T. Kato, S. Hatooka, T. Mitsudomi, M. Suyama, Y. Kagami, M. Ogura, M. Ando, Y. Sugimura, K. Tajima
Current and future trends in management and treatment of Klatskin tumour
B. Launois, S. Wemyss-Holden, G. J. Maddern
Preoperative parameters to predict tumor volume in Japanese patients with nonpalpable prostate cancer
Y. Furuya, H. Fuse, O. Nagakawa, M. Masai
Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic or unresectable localized non-small-cell lung cancer
Y. H. Kim, J. S. Kim, Y. H. Choi, K. H. In, H. S. Park, D. S. Hong, T. J. Jeong, Y. Y. Lee, E. Nam, S. N. Lee, K. S. Lee, H. K. Kim
Renal angiomyolipoma with minimal fat
Y. Hosokawa, T. Kinouchi, Y. Sawai, M. Mano, H. Kiuchi, N. Meguro, O. Maeda, M. Kuroda, M. Usami
Severe gustatory disorder caused by cisplatin and etoposide
Y. Minakata, T. Yamagata, H. Nakanishi, T. Nishimoto, M. Nakanishi, M. Mune, S. Yukawa
A patient with small-cell carcinoma of the stomach with long survival after percutaneous microwave coagulating therapy (PMCT) for liver metastasis
H. Tanemura, H. Ohshita, A. Kanno, M. Kusakabe, E. Tomita, Y. Nishigaki, A. Sugiyama, T. Yamada